Pioneer


your Pathway Discovery


Expert-coded by chemists and engineered by computer scientists, SYNTHIA™ retrosynthesis software draws from an ever-expanding reaction database and advanced algorithms to analyze tens of thousands of unique pathways based on your search criteria.


Accelerate your drug discovery research and maximize your time at the bench with the license package that suits your needs.


SigmaAldrich.com/SYNTHIA


©2021 Merck KGaA, Darmstadt, Germany and/or its affiliates. All Rights Reserved. Merck, the vibrant M, Sigma- Aldrich and Synthia are trademarks of Merck KGaA, Darmstadt, Germany or its affiliates.


All other trademarks are the property of their respective owners. Detailed information on trademarks is available via publicly accessible resources.


Lit. No. MK_AD5437EN Ver. 2.0 04/2021


The life science business of Merck operates as MilliporeSigma in the U.S. and Canada.


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42